Cromwell Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Cromwell Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$384K	Hold	6,661	–	–	0.17%	104
2026 Q1	$404K	Hold	6,661	–	–	0.23%	87
2025 Q4	$359K	Sell	6,661 -49	-0.7%	-$2.36K	0.2%	100
2025 Q3	$303K	Buy	6,710 +54	+0.8%	+$2.52K	0.16%	119
2025 Q2	$308K	Sell	6,656 -49	-0.7%	-$2.4K	0.19%	107
2025 Q1	$409K	Hold	6,705	–	–	0.26%	81
2024 Q4	$379K	Buy	6,705 +10	+0.1%	+$559	0.22%	85
2024 Q3	$346K	Buy	6,695 +38	+0.6%	+$1.78K	0.22%	90
2024 Q2	$276K	Buy	+6,657	New	+$298K	0.17%	112

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Cromwell Holdings's BMY Position: Q2 2026 in Review

Cromwell Holdings held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 6,661 shares worth $384K. The position accounts for 0.17% of the portfolio, ranked #104.

Cromwell Holdings first reported a position in BMY in Q2 2024 and has held it in 9 quarters since. The position peaked at $409K in Q1 2025. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Cromwell Holdings held 6,661 shares of Bristol-Myers Squibb worth $384K as of Q2 2026.
Cromwell Holdings left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.17% of Cromwell Holdings's portfolio in Q2 2026, its #104 holding.
Cromwell Holdings first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 9 quarters since.
Cromwell Holdings's Bristol-Myers Squibb position peaked at $409K in Q1 2025.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.